DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Examination of Cognitive Function in Obesity and Following Weight Loss

Withdrawn

Conditions: Bariatric Surgery Candidate
Obesity
Weight Loss

Interventions: Other: Medical Weight Loss Program
Procedure: Bariatric Surgery

First Posted Date: 2016-12-15

Last Posted Date: 2018-09-27

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT02994186

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Phase 3

Active, not recruiting

Conditions: Stevens-Johnson Syndrome
Toxic Epidermal Necrolyses

Interventions: Drug: Harmonized supportive care
Drug: Etanercept 50 mg sc day 1 and day 4

First Posted Date: 2016-12-08

Last Posted Date: 2025-04-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2

Registration Number: NCT02987257

Locations: 🇺🇸
University of California, Davis Medical Center, Sacramento, California, United States
🇺🇸
Valleywise Health Medical Center, Phoenix, Arizona, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States

and more 11 locations

A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy

Not Applicable

Completed

Conditions: Polypharmacy
Care Transitions
Geriatric Syndromes

First Posted Date: 2016-12-01

Last Posted Date: 2023-07-19

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 372

Registration Number: NCT02979353

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

Phase 4

Completed

Conditions: Asthmatic

Interventions: Drug: IIV4
Drug: ccIIV4

First Posted Date: 2016-11-18

Last Posted Date: 2018-04-23

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 40

Registration Number: NCT02967393

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Duke Clinical Vaccine Unit, Durham, North Carolina, United States
🇺🇸
Vanderbilt Vaccine Research Program, Nashville, Tennessee, United States

and more 1 locations

Vanderbilt Childhood Obesity Registry

Active, not recruiting

Conditions: Childhood Obesity
Childhood Onset Obesity
Pediatric Obesity

First Posted Date: 2016-11-08

Last Posted Date: 2025-03-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 3000

Registration Number: NCT02957916

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery

Phase 1

Completed

Conditions: Obesity

Interventions: Procedure: Oral Glucose Tolerance Test (OGTT)
Drug: Human Ghrelin
Drug: Saline

First Posted Date: 2016-11-03

Last Posted Date: 2023-02-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 70

Registration Number: NCT02953587

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial

Not Applicable

Completed

Conditions: Knee Arthroplasty, Total
Osteoarthritis
Radiologic Tibiofemoral Osteoarthritis

Interventions: Procedure: Genicular Nerve RFA
Procedure: Sham Genicular Nerve RFA

First Posted Date: 2016-10-27

Last Posted Date: 2020-10-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 60

Registration Number: NCT02947321

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Nutrition and Exercise Study to Understand Metabolic Syndrome

Phase 2

Completed

Conditions: Obesity
Insulin Resistance
Metabolic Syndrome

Interventions: Behavioral: Health education
Behavioral: Yoga

First Posted Date: 2016-09-14

Last Posted Date: 2017-01-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 67

Registration Number: NCT02899910

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Phase 1

Recruiting

Conditions: Pure Autonomic Failure
Autonomic Failure
Multiple System Atrophy
Parkinson Disease
Orthostatic Hypotension

Interventions: Drug: Midodrine
Drug: Droxidopa
Drug: Placebo

First Posted Date: 2016-09-12

Last Posted Date: 2024-12-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 34

Registration Number: NCT02897063

Locations: 🇺🇸
Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville, Tennessee, United States

Guanfacine for PONV and Pain After Sinus Surgery

Not Applicable

Completed

Conditions: Pain, Postoperative
Postoperative Nausea and Vomiting

Interventions: Drug: Placebo
Drug: Guanfacine

First Posted Date: 2016-08-30

Last Posted Date: 2019-01-03

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 84

Registration Number: NCT02882854

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy